Blog In the News News Releases

Paying for CTs and MRIs, but not (yet) for the ‘most effective service’

January 26, 2015

By Margie Coloian

The medical paradigm is about diagnosing disease, according to Mitchell Katz, MD. “When doctors are trained to focus on finding the diagnosis,” Katz says, “the response will always be testing. That’s just the way doctors are trained.” But does a medical system that is laser-focused on endless tests, and a multitude of subsequent treatments, deliver the highest value care? Katz thinks not.

Read More

Supporting ‘breakthrough ideas’ that help patients decide

January 15, 2015
By Margie Coloian

Harlan Krumholz, MD wants to dispel two widely believed myths about healthcare: that more of it is better, and that the costliest is the highest quality. Too often patients are not aware of all the healthcare choices that are available to them and the reasonable range of decisions that could be made.

Read More

Prescribing the end-of-life conversation

January 11, 2015
By Dr. Angelo Volandes

The Boston Globe

LIKE MOST doctors, I was a young resident, fresh out of medical school, when I had my first experience with the American way of mistreating the dying.

Read More

You made it happen: Great progress, an enduring promise

January 14, 2015

By Vikas Saini, MD and Shannon Brownlee, MSc

Thanks to all of you, this has been an extraordinary year. Two RightCare regional meetings have been held, the first in Denver, and another in Washington, DC, and there are at least eight more scheduled around the U.S. for 2015. We’ve doubled the membership for the RightCare Alliance; so many clinicians across the country are eager to learn how they can help reshape healthcare to make it more effective and just.

Read More

In Memoriam

Thomas B. Graboys, MD  The Lown Institute family mourns the loss of Thomas B. Graboys, MD, president emeritus of the Institute and former director of the Lown Cardiovascular Center, who died on January 5. Dr. Graboys was a senior physician at the Brigham and Women’s Hospital and a professor of medicine at Harvard Medical School. […]

Read More

Still standing up after sitting in

January 12, 2015

By Margie Coloian

Anybody who followed the controversy over the diabetes drug rosiglitazone (trade name Avandia) knows that Dr. Steve Nissen played a central role in the Food and Drug Administration’s decision to issue a warning about the drug’s cardiovascular risks. He was also involved in blowing the whistle in 2001 in identifying the cardiovascular risk of the pain medication Vioxx. But Nissen’s history of activism began long before.

Read More

Page 35 of 45« First...102030...3334353637...40...Last »